Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add filters








Language
Year range
1.
Experimental & Molecular Medicine ; : 216-222, 2010.
Article in English | WPRIM | ID: wpr-203591

ABSTRACT

Growth factor stimulation induces Y783 phosphorylation of phosphoinositide-specific PLC-gamma1, and the subsequent activation of this enzyme in a cellular signaling cascade. Previously, we showed that a double point mutation, Y509A/F510A, of PLC-gamma1, abolished interactions with translational elongation factor 1-alpha. Here, we report that the Y509A/F510A mutant PLC-gamma1 displayed extremely high levels of Y783 phosphorylation and enhanced catalytic activity, compared to wild-type PLC-gamma1, upon treatment of COS7 cells with EGF. In quiescent COS7 cells, the Y509A/F510A mutant PLC-gamma1 exhibited a constitutive hydrolytic activity, whereas the wild-type counterpart displayed a basal level of activity. Upon treatment of COS7 cells with EGF, the Y783F mutation in Y509A/F510A PLC-gamma1 (Y509A/F510A/Y783F triple mutant) cells also led to an enhanced catalytic activity, whereas Y783F mutation alone displayed a basal level of activity. Our results collectively suggest that the Y509A/F510A mutant is more susceptible to receptor tyrosine kinase-induced Y783 phosphorylation than is wild-type PLC-gamma1, but no longer requires Y783 phosphorylation step for the Y509A/F510A mutant PLC-gamma1 activation in vivo.


Subject(s)
Animals , Rats , Amino Acid Substitution/drug effects , COS Cells , Chlorocebus aethiops , Enzyme Activation/drug effects , Epidermal Growth Factor/pharmacology , Hydrolysis/drug effects , Mutant Proteins/metabolism , Phosphatidylinositols/metabolism , Phospholipase C gamma/genetics , Phosphorylation/drug effects , Phosphotyrosine/metabolism , Point Mutation/genetics
2.
Experimental & Molecular Medicine ; : 176-184, 2007.
Article in English | WPRIM | ID: wpr-90615

ABSTRACT

We investigated the co-stimulatory role of a cell-surface protein, CD99. Co-ligation of CD99 and suboptimal CD3 induced T-cell activation to a level comparable to that obtained with optimal CD3 or CD3+CD28. We also noted concomitant enhancement of the earliest T-cell receptor (TCR) signaling events. In addition, co-ligation of CD99 and CD3 led to translocation of TCR complexes into the lipid raft, without concomitant migration of CD99 to the raft, and consequent enhancement of TCR zeta-mediated signal 1. These data demonstrate the unique properties of CD99 co-stimulation that distinguish this molecule from CD28 and other raft-resident co-stimulatory factors.


Subject(s)
Humans , Antigens, CD/immunology , CD3 Complex/immunology , Cell Adhesion Molecules/immunology , Down-Regulation , Jurkat Cells , Lymphocyte Activation/immunology , Membrane Microdomains/immunology , Membrane Proteins/immunology , Phosphorylation , Phosphotyrosine/metabolism , Protein Transport , Receptors, Antigen, T-Cell/immunology , T-Lymphocytes/immunology
3.
Experimental & Molecular Medicine ; : 703-717, 2006.
Article in English | WPRIM | ID: wpr-106414

ABSTRACT

Diverse signaling pathways have been proposed to regulate store-operated calcium entry (SOCE) in a wide variety of cell types. However, it still needs to be determined if all of these known pathways operate in a single cell type. In this study, we examined involvement of various signaling molecules in SOCE using human fibroblast cells (HSWP). Bradykinin (BK)-stimulated Ca2+ entry, previously shown to be via SOCE, is enhanced by the addition of vanadate, an inhibitor of tyrosine phosphatases. Furthermore, SOCE is regulated by cytochrome P-450, as demonstrated by the fact that the products of cytochrome P-450 activity (14,15 EET) stimulated SOCE while econazole, an inhibitor of cytochrome P450, suppressed BK-stimulated Ca2+ entry. In contrast, Ca2+ entry was unaffected by the guanylate cyclase inhibitor LY83583, or the membrane permeant cyclic GMP analog 8-bromo-cyclic GMP (8-Br-cGMP). Neither nitric oxide donors nor phorbol esters affected BK-stimulated Ca2+ entry. SOCE in HSWP cells is primarily regulated by tyrosine phosphorylation and the cytochrome P-450 pathway, but not by cyclic GMP, nitric oxide, or protein kinase C. Thus, multiple pathways do operate in a single cell type leading to the activation of Ca2+ entry and some of these signaling pathways are more prominently involved in regulating calcium entry in different cell types.


Subject(s)
Humans , Vanadates/pharmacology , Tetradecanoylphorbol Acetate/pharmacology , Protein Tyrosine Phosphatases/metabolism , Phosphotyrosine/metabolism , Phosphorylation/drug effects , Nitric Oxide/metabolism , Fibroblasts , Epidermal Growth Factor/pharmacology , Enzyme Inhibitors/pharmacology , Econazole/pharmacology , Cytochrome P-450 Enzyme System/antagonists & inhibitors , Cyclic GMP/analogs & derivatives , Cells, Cultured , Calcium Channels/metabolism , Calcium/metabolism , Bradykinin/pharmacology
4.
Experimental & Molecular Medicine ; : 350-357, 2003.
Article in English | WPRIM | ID: wpr-171367

ABSTRACT

STATs (signal transducers and activators of transcription) are proteins with dual functions: signal transducers in the cytoplasm and transcriptional activators in the nucleus. STAT proteins act as transcription factors activated by phosphorylation on its tyrosine residues upon stimulation by various cytokines. The phosphorylated STAT molecules then form homo- or heterodimers through SH2-mediated interaction and translocate into the nucleus to activate the transcription of various target genes. STAT5 recognizes the interferon-gamma activated site TTCNNNGAA (GAS sequence) in the promoter region of the beta-casein gene. Except for prolactin-dependent beta-casein production in mammary gland cells, the biological consequences of STAT5a activation in various systems are not clear. Here we showed that STAT5a was phosphorylated 10 min after desferrioxamine (DFO) treatment, and reached a maximum induction at 4 h in mammary epithelial cells (HC11) and transfected COS-7 cells. Under hypoxic conditions (2% O2), a maximal phosphorylation of STAT5a was observed within 6 h. EMSA (electrophoretic mobility shift assay) showed that DFO or hypoxia enhanced the binding activities of STAT5a DNA to beta-casein gene promoter in mammary epithelial cells (HC11) and transfected COS-7 cells. These results showed that DFO or hypoxia induces tyrosine phosphorylation of STAT5a and also increases the binding activity of STAT5a DNA in mammary epithelial cells. Our data suggest that the STAT5 may act as a mediator in hypoxia-mediated gene expression.


Subject(s)
Animals , Mice , Hypoxia/genetics , Caseins/genetics , Cell Line , DNA/genetics , DNA-Binding Proteins/metabolism , Deferoxamine/pharmacology , Epithelial Cells/drug effects , Gene Expression Regulation , Mammary Glands, Animal/cytology , Phosphorylation/drug effects , Phosphotyrosine/metabolism , Promoter Regions, Genetic/genetics , Protein Binding , Response Elements/genetics , Trans-Activators/metabolism
5.
Experimental & Molecular Medicine ; : 486-493, 2003.
Article in English | WPRIM | ID: wpr-197474

ABSTRACT

The 2',3'-cyclic nucleotide 3'-phosphodiesterase (CNP), a protein of unknown function in vivo, is abundantly expressed in myelinating glia in two isoforms, CNP1 and CNP2. In this study, immunoblot analysis showed that CNP1 is the major isoform in adult forebrain, and that both isoforms are included in the postsynaptic density (PSD) fraction and tyrosine-phosphorylated at the basal level. However, subcellular distribution and detergent extraction data showed that CNP is nonspecifically associated with the PSD fraction. Immunocytochemistry revealed that CNP is detected, in a weak but punctate pattern, in dissociated rat hippocampal neurons of 3 days to 2 weeks in vitro. The CNP-positive punctae were distributed throughout soma and dendrites, and distinct from PSD95-positive ones. Immunoblot analysis indicated that CNP is also expressed in neuronal stem cell lines, HiB5 and F11. Interestingly, in addition to the known two isoforms, a new CNP isoform of MW 45 kDa was expressed in these cell lines and was the major type of isoform in F11 cells. Taken together, our data suggest that CNP is expressed in the early stage of in vitro development and nonspecifically included in the adult rat PSD fraction.


Subject(s)
Animals , Rats , 2',3'-Cyclic-Nucleotide Phosphodiesterases/metabolism , Aging/physiology , Cells, Cultured , Hippocampus/cytology , Immunohistochemistry , Nerve Tissue Proteins/metabolism , Neurons/metabolism , Phosphotyrosine/metabolism , Prosencephalon/cytology , Rats, Sprague-Dawley , Substrate Specificity
SELECTION OF CITATIONS
SEARCH DETAIL